Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry).


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 10 06 2019
revised: 21 08 2019
accepted: 26 08 2019
pubmed: 6 10 2019
medline: 27 3 2020
entrez: 6 10 2019
Statut: ppublish

Résumé

The protective effect of obesity on mortality in acute coronary syndromes (ACS) patients remains debated. We aimed at evaluating the impact of obesity on ischemic and bleeding events as possible explanations to the obesity paradox in ACS patients. For the purpose of this substudy, patients enrolled in the START-ANTIPLATELET registry were stratified according to body mass index (BMI) into 3 groups: normal, BMI <25 kg/m

Identifiants

pubmed: 31585697
pii: S0002-9149(19)30996-8
doi: 10.1016/j.amjcard.2019.08.030
pii:
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1662-1668

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Paolo Calabrò (P)

Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy. Electronic address: paolo.calabro@unicampania.it.

Elisabetta Moscarella (E)

Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Felice Gragnano (F)

Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Arturo Cesaro (A)

Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Pia Clara Pafundi (PC)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Caserta, Italy.

Giuseppe Patti (G)

Università degli Studi, L'Aquila, Italy; Dipartimento di Malattie dell'Apparato Cardiovascolare, Policlinico Campus Bio-Medico, Roma, Italy.

Ilaria Cavallari (I)

Dipartimento di Malattie dell'Apparato Cardiovascolare, Policlinico Campus Bio-Medico, Roma, Italy.

Emilia Antonucci (E)

Arianna Anticoagulazione Foundation, Bologna, Italy.

Plinio Cirillo (P)

Department of Advanced Biomedical Sciences, School of Medicine, "Federico II" University, Naples, Italy.

Pasquale Pignatelli (P)

Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.

Gualtiero Palareti (G)

Arianna Anticoagulazione Foundation, Bologna, Italy.

Ferdinando Carlo Sasso (FC)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Caserta, Italy.

Vittorio Pengo (V)

Department of Cardiothoracic and Vascular Sciences, University Hospital of Padua, Padua, Italy.

Paolo Gresele (P)

Department of Medicine, Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Rossella Marcucci (R)

Department of Experimental and Clinical Medicine, Center for Atherothrombotic diseases, University of Florence, Florence, Italy.

Marzia Conte (M)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Fabio Fimiani (F)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Luigi Di Serafino (L)

Department of Advanced Biomedical Sciences, School of Medicine, "Federico II" University, Naples, Italy.

Maurizio Del Pinto (M)

Department of Medicine, Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Gentian Denas (G)

Department of Cardiothoracic and Vascular Sciences, University Hospital of Padua, Padua, Italy.

Daniele Pastori (D)

Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.

Camilleri Eleonora (C)

Department of Experimental and Clinical Medicine, Center for Atherothrombotic diseases, University of Florence, Florence, Italy.

Tiziana Fierro (T)

Department of Medicine, Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH